These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4109748)

  • 21. Malignant hyperthermia: molecular defects in membrane permeability.
    Cheah KS; Cheah AM
    Experientia; 1985 May; 41(5):656-61. PubMed ID: 3888661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Malignant hyperpyrexia.
    Furniss P
    Br Med J; 1975 Jan; 1(5949):92. PubMed ID: 1109671
    [No Abstract]   [Full Text] [Related]  

  • 23. The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.
    Britt BA; Endrenyi L; Kalow W; Peters PL
    Can Anaesth Soc J; 1976 Nov; 23(6):624-35. PubMed ID: 990979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of procaine in acquired malignant hyperthermia in a patient with malignant melanoma metastatic to the parathyroid gland: a case report.
    Borden H; Hummer GJ; Landon CW; Paris J
    Can Anaesth Soc J; 1976 Nov; 23(6):616-23. PubMed ID: 990978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten cases of malignant hyperthermia in Norway.
    Stovner J; Innes KR; Holen A
    Can Anaesth Soc J; 1976 Sep; 23(5):518-26. PubMed ID: 971460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophy of the branchial muscles. A case with unusual features.
    Lambert CD; Young JR
    J Neurol Neurosurg Psychiatry; 1976 Aug; 39(8):810-6. PubMed ID: 956867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.
    Britt BA; Endrenyi L; Peters PL; Kwong FH; Kadijevic L
    Can Anaesth Soc J; 1976 May; 23(3):263-84. PubMed ID: 938964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant hyperthermia and althesin.
    Honda N; Konno K; Itohda Y; Nishino M; Matsushima S; Haseba S; Honda Y; Gotoh Y
    Can Anaesth Soc J; 1977 Jul; 24(4):514-21. PubMed ID: 890563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histological, histochemical, and ultrastructural findings in malignant hyperthermia (author's transl)].
    Gullotta F; Helpap B
    Virchows Arch A Pathol Anat Histol; 1975 Aug; 367(3):181-94. PubMed ID: 808899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is malignant hyperpyrexia muscle denervated?
    Moulds RF
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):975-8. PubMed ID: 591976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The caffeine test of isolated human muscle in relation to malignant hyperthermia.
    Kalow W; Britt BA; Richter A
    Can Anaesth Soc J; 1977 Nov; 24(6):678-94. PubMed ID: 589505
    [No Abstract]   [Full Text] [Related]  

  • 32. Temperature perturbation studies of sarcoplasmic reticulum from malignant hyperthermia pig muscle.
    Nelson TE; Bee DE
    J Clin Invest; 1979 Oct; 64(4):895-901. PubMed ID: 479374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic background to malignant hyperpyrexia revealed by serum creatine phosphokinase estimations in asymptomatic relatives.
    Isaacs H; Barlow MB
    Br J Anaesth; 1970 Dec; 42(12):1077-84. PubMed ID: 5504449
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant hyperpyrexia and myopathy.
    Lancet; 1970 May; 1(7657):1162. PubMed ID: 4192110
    [No Abstract]   [Full Text] [Related]  

  • 35. Malignant hyperthermia: a statistical review.
    Britt BA; Kalow W
    Can Anaesth Soc J; 1970 Jul; 17(4):293-315. PubMed ID: 4246871
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant hyperpyrexia.
    Relton JE; Britt BA; Steward DJ
    Br J Anaesth; 1973 Mar; 45(3):269-75. PubMed ID: 4581791
    [No Abstract]   [Full Text] [Related]  

  • 37. Inheritance of malignant hyperpyrexia.
    King JO; Denborough MA; Zapf PW
    Lancet; 1972 Feb; 1(7746):365-70. PubMed ID: 4109748
    [No Abstract]   [Full Text] [Related]  

  • 38. Myopathy and malignant hyperpyrexia.
    Denborough MA; Ebeling P; King JO; Zapf P
    Lancet; 1970 May; 1(7657):1138-40. PubMed ID: 4192097
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.